PANADOL EXTEND CAPLET 665 mg
Product details
Registration number: SIN12406P
Classification: General Sale List
Active ingredients: PARACETAMOL
Strength: 665 mg
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Registrant: HALEON SINGAPORE PTE. LTD.
ATC code: N02BE01
HSA approval date: 29 August 2003
Manufacturer(s):
- Haleon Ireland Dungarvan Limited
- GlaxoSmithKline Consumer Healthcare Australia Pty Limited
- GLAXO WELLCOME S.A.
- Sterling Drug (Malaya) Sdn. Bhd (Primary packager and Secondary packager)
- Granules India Limited (Drug Product Intermediate)
- Milan Laboratories (India) Pvt. Ltd.
Manufacturing country/countries: SPAIN; MALAYSIA; IRELAND; AUSTRALIA; INDIA
What are the HSA registration number and classification for PANADOL EXTEND CAPLET 665 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12406P
Classification: General Sale List
What active ingredients and strength are recorded for PANADOL EXTEND CAPLET 665 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: PARACETAMOL
Strength: 665 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PANADOL EXTEND CAPLET 665 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for PANADOL EXTEND CAPLET 665 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: HALEON SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for PANADOL EXTEND CAPLET 665 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Haleon Ireland Dungarvan Limited
- GlaxoSmithKline Consumer Healthcare Australia Pty Limited
- GLAXO WELLCOME S.A.
- Sterling Drug (Malaya) Sdn. Bhd (Primary packager and Secondary packager)
- Granules India Limited (Drug Product Intermediate)
- Milan Laboratories (India) Pvt. Ltd.
Manufacturing country/countries: SPAIN; MALAYSIA; IRELAND; AUSTRALIA; INDIA
Where can I look up PANADOL EXTEND CAPLET 665 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12406P or the exact product name PANADOL EXTEND CAPLET 665 mg. The general register link does not preselect this product.
What are the source dates for this PANADOL EXTEND CAPLET 665 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PANADOL EXTEND CAPLET 665 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12406P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)